SLC1A2

SLC1A2

SLC1A2 Molekülinformation

Molecule Name
Excitatory amino acid transporter 2
Molekülalias
DEE41, EAAT2, EIEE41, GLT-1, GLT1, HBGT
Drug Development Progress
Anzahl der klinischen Arzneimittel2
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Target-Alias
GLT1,Glutamate/aspartate transporter II,Sodium-dependent glutamate/aspartate transporter 2,Solute carrier family 1 member 2,SLC1A2,EAAT2
Molekülhintergrund
This gene encodes a member of a family of solute transporter proteins. The membrane-bound protein is the principal transporter that clears the excitatory neurotransmitter glutamate from the extracellular space at synapses in the central nervous system. Glutamate clearance is necessary for proper synaptic activation and to prevent neuronal damage from excessive activation of glutamate receptors. Improper regulation of this gene is thought to be associated with several neurological disorders. Alternatively spliced transcript variants of this gene have been identified. [provided by RefSeq, Jun 2017]

SLC1A2 Produktliste

Species
  • Human(1)
Tag
  • His Tag & Flag Tag(1)
Host
  • HEK293(1)
Conjugate
  • Unconjugated(1)
Grade
  • RUO(1)
Low Endotoxin
  • No(1)
MoleculeCat. No.Product NameArtHostStructurePurityActivitySize&PriceAdd to Cart
SLC1A2
Human SLC1A2 Protein, Flag,His Tag (Detergent)
Human
HEK293
SDS-PAGE
ELISA

$805.00

20ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
[18F]RP-115[18F]RP-115Phase 2 ClinicalRio pharmaceuticals Inc
Alzheimer Disease; Dementia; Frontotemporal Dementia
Details
iQ-007iQ-007Phase 1 ClinicaliQure Pharma Inc
Drug Resistant Epilepsy; Epilepsies, Partial; Epilepsy; Neuralgia
Details
Customer Reviews